XOMAP Q2 2018 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-79.3% YoY

Gross Profit

$2M83.3% margin

Operating Income

-$3M-132.6% margin

Net Income

-$2M-86.3% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+387.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$770,000

Balance Sheet

Total Assets

$41M

Total Liabilities

$36M

Stockholders' Equity

$5M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$11M	-79.3%
Gross Profit	$2M	$9M	-78.3%
Operating Income	-$3M	$1M	-328.1%
Net Income	-$2M	$285,000	-783.2%